Cost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK Setting
Crossref DOI link: https://doi.org/10.1007/s13300-018-0478-1
Published Online: 2018-08-10
Published Print: 2018-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Evans, Marc http://orcid.org/0000-0003-0671-0778
Mehta, Roopa
Gundgaard, Jens
Chubb, Barrie
Funding for this research was provided by:
Novo Nordisk
Article History
Received: 20 June 2018
First Online: 10 August 2018